论文部分内容阅读
解放军总医院罗成华博士在研究中发现,骨骼肌 细胞可分泌抑瘤活性物质,用其能开发出新一代抗肿瘤药物。 临床资料表明,恶性肿瘤极少在体积庞大且血运丰富的骨骼肌组织内形成转移灶,提示骨骼肌组织可能对转移瘤具有广泛而强烈的抵御机制。针对这一临床现象,罗成华博士在导师蒋彦永教授指导下,对骨骼肌的抑瘤机制进行了深入研究。结果发现,骨骼肌细胞能分泌抑瘤活性物质,初步证实此类骨骼肌源性抑瘤
PLA General Hospital Dr. Luo Chenghua found in the study, skeletal muscle cells can secrete tumor suppressor substances, with which they can develop a new generation of anti-tumor drugs. Clinical data show that malignant tumors are rarely formed in the bulky and blood-rich skeletal muscle tissue metastases, suggesting that skeletal muscle tissue may have a broad and strong resistance mechanism of metastases. In response to this clinical phenomenon, Dr. Luo Chenghua under the guidance of the mentor Professor Jiang Yanyong, on the inhibition mechanism of skeletal muscle in-depth study. The results showed that skeletal muscle cells can secrete anti-tumor active substances, preliminary evidence of such skeletal muscle-derived tumor suppressor